Gnome Sciences — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Gnome Sciences is a private, revenue-generating contract research organization (CRO) and specialized lab services provider operating in the genetics and genomics sector. Its core business is offering a suite of molecular pathology and biomarker analysis services to support drug discovery and clinical trials, leveraging its CLIA-certified lab in Ohio. The company has demonstrated adaptability by developing COVID-19 study services and highlights expertise in complex immunohistochemistry (IHC) and tissue microarray construction. Gnome Sciences functions as a B2B service provider rather than a therapeutic or diagnostic product developer.

Genetics & Genomics

Technology Platform

Integrated suite of CLIA-certified laboratory services for tissue-based and molecular biomarker analysis, including advanced histopathology (IHC, tissue microarrays), genomic DNA services, gene expression, and pharmacogenomic testing.

Opportunities

Growing demand for biomarker-driven drug development and spatial biology services presents a significant market.

Its CLIA certification allows it to capture high-value clinical trial support work.

The adaptable model, shown with COVID-19 services, allows entry into emerging research areas.

Risk Factors

High competition in the CRO/lab services market from large global players and niche specialists.

Revenue is directly tied to client R&D budgets, creating cyclical vulnerability.

Maintaining cutting-edge technology and CLIA compliance requires continuous investment.

Competitive Landscape

Gnome Sciences competes in the fragmented contract research and lab services market. It faces competition from large, full-service CROs (e.g., LabCorp, IQVIA), specialized central labs, and academic core facilities. Its differentiation hinges on deep expertise in complex IHC and integrated tissue-molecular analysis within a CLIA environment.

More companies in Diagnostics & Precision Medicine →More companies in United States →